article thumbnail

COVID-19 Showcased Failed Global Cooperation

Bill of Health

However, the deep wounds of the pandemic remain, compelling those concerned about this pandemic and future health emergencies to account for catastrophic failures by those in power. Public health emergencies aren’t entirely preventable. That has created deep inequities in access to health products that can save lives.

COVID-19 299
article thumbnail

The Case for Procurement Transparency

Bill of Health

Global health activists and civil society organizations who worked transnationally to curtail what came to be referred to as “vaccine apartheid” faced a pharmaceutical industry that globally relied on secrecy, capital-friendly trade laws, and brute economic force to shirk considerations of human rights.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

California Enters Insulin Manufacturing: Can We Expect to See a California Effect?

Bill of Health

By Aparajita Lath For over 100 years, policy makers and pharmaceutical manufacturers in the U.S. have debated whether the government should produce drugs and biologics. Until now, private industry has largely won– but that may be changing, due to a recent California initiative. Now, the tide is turning.

article thumbnail

Drug Discovery Outsourcing Market Expected to Reach $7.5B by 2033

HIT Consultant

The research report on the drug discovery outsourcing market states that the pharmaceutical industry is expanding thoroughly with new extensions and high-end research programs. Moreover, the government projects and the bilateral relationship are also anticipated to increase drug production.

article thumbnail

U.S. Hospitals Will Lose $323 Billion in 2020 – Before Accounting for Growing COVID Cases

Health Populi

Thus, the AHA issued a caveat on the projection of $323 bn losses for 2020 with the proviso that, without reducing the spread of the virus and patients entering inpatient care, health system financial losses will be greater than this forecast. What’s the worth of $323 billion? declines in expected inpatient volume and 34.5%

Hospitals 124
article thumbnail

Reasonable Pricing Clauses: A First Step Toward Ensuring Taxpayers a Fair Return on their Public R&D Investment

Bill of Health

Pressure from Senator Bernie Sanders, Chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee seems to have catalyzed the administration to make this move. pharmaceutical market. However, reasonable pricing requirements within federal agreements are not new, nor are the unsubstantiated concerns around them.

COVID-19 205
article thumbnail

No Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge

Bill of Health

government funding, announced that it felt “a special obligation … to use our resources to bring this pandemic to an end as quickly as possible.” government purchased millions of doses of Moderna’s mRNA vaccine, along with large quantities of vaccines manufactured by Pfizer. By Jorge L. Updating” the Pledge. From 2020 to 2022, the U.S.